TG THERAPEUTICS, INC.: net_income
| Value | {"amount": 12672000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | superseded |
| Entity | TG THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3a439db1-1564-411b-ab22-d5aa449b38d5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001437749-24-006144Retrieved: 2026-08-19T09:42:11.974157+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001316/net-income/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3a439db1-1564-411b-ab22-d5aa449b38d5
History
- no predecessors — first report